Abstract S1P (sphingosine 1-phosphate) is the ligand for a family of specific G-protein-coupled receptors that regulate a wide variety of important cellular functions, including vascular maturation, angiogenesis, cell growth, survival, cytoskeletal rearrangements and cell motility. However, S1P also may have intracellular functions. In this review, we discuss two examples that clearly indicate that intracellularly generated and exogenous S1P can regulate biological processes by divergent pathways.
Introduction
S1P (sphingosine 1-phosphate), a sphingolipid metabolite found in organisms as diverse as plants, yeast, nematode worms, flies and mammals, is a potent regulator of a wide spectrum of important biological processes [1] . S1P is produced by phosphorylation of sphingosine catalysed by SphK (sphingosine kinase), a highly conserved enzyme that is activated by many agonists and stimuli [1, 2] . S1P actions are mediated by binding to a family of five specific G-proteincoupled receptors, S1P 1 -S1P 5 , which are differentially expressed and coupled to a variety of G-proteins [1, [3] [4] [5] . There is no doubt that the most important functions of S1P are mediated through its receptors, and these include regulation of angiogenesis, vascular maturation, cardiac development, neuronal survival and immunity [1, 3, 4] . The importance of these receptors has been most clearly shown by mutations and disruptions of S1P receptor genes. For example, mutations in S1P 2 lead to abnormal split heart development in the zebrafish [6] . Moreover, deletion of S1P 1 in mice revealed that it is essential for vascular maturation and migration of smooth muscle cells and pericytes around newly formed endothelium [7] . An exciting recent development with important clinical implications for S1P receptor signalling was the finding that the immunosuppressive drug FTY720, a sphingosine analogue, is phosphorylated by SphK to an active phosphorylated form which then, acting via S1P receptors, induces lymphopenia [8, 9] . These studies implied a role for S1P receptors in lymphocyte homing and immunoregulation.
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homoeostasis [10, 11] , cell growth [12] [13] [14] and suppression of apoptosis [15] [16] [17] . Dissection of the intra-and extracellular actions of S1P is difficult, as intracellular targets have not been definitively identified and it has been shown that S1P, by binding to its receptors, can stimulate SphK to increase its own intracellular levels [18] . On the other hand, growth factors, such as PDGF (platelet-derived growth factor), can bind to their receptors to activate and recruit SphK to the leading edge of the cell [19] , where it produces S1P to spatially and temporally stimulate cell-surface S1P 1 in an autocrine or paracrine manner [20] leading to activation of downstream signals crucial for cell movement [19, 20] . It has been proposed that the PDGF receptor is in fact tethered to S1P 1 , providing a platform for integrative signalling by these two types of receptor [21] . Another complicating factor in discriminating between intra-and extracellular actions of S1P is the fact that it can be specifically transported into cells by the cystic fibrosis transmembrane regulator (CFTR) [22] , which could function to terminate extracellular signals as well as to initiate intracellular signals. In this review, we will describe two examples that show that exogenous and intracellularly generated S1P can affect cellular processes by distinct pathways.
SphK1 and generation of intracellular S1P, but not exogenous S1P, potentiate TNF-α (tumour necrosis factor α)-stimulated BH 4 (tetrahydrobiopterin) biosynthesis in C6 glioma cells
In astroglial cells, the biosynthesis of BH 4 , the coenzyme required for NO synthesis and hydroxylation of tyrosine and tryptophan, is stimulated by various proinflammatory cytokines, including TNF-α. These induce expression of GTP cyclohydrolase, the rate-limiting enzyme in the de novo pathway for BH 4 biosynthesis. We observed that TNF-α stimulates iNOS (inducible nitric oxide synthase), which requires BH 4 for its activity, and GTP cyclohydrolase expression by divergent pathways [23] . Whereas TNF-α stimulated iNOS expression via a ceramide-dependent pathway, TNF-α regulated GTP cyclohydrolase expression independently of ceramide generation, and the sphingolipid metabolite S1P, but not ceramide, potentiated GTP cyclohydrolase mRNA expression induced by TNF-α. Conversely, TNF-α-induced SphK activation and generation of S1P did not modulate expression of iNOS. Thus TNF-α induces the coordinate expression of iNOS and GTP cyclohydrolase via ceramide-and S1P-dependent pathways, respectively [23] . Differential regulation of iNOS expression and levels of its cofactor BH 4 may be physiolologically relevant, as BH 4 has other important functions, especially in hydroxylation of the aromatic amino acids. Thus cytokine-dependent induction of iNOS and BH 4 synthesis should be co-ordinately regulated only in cell types where NO production is important.
As TNF-α stimulates GTP cyclohydrolase expression via a ceramide-independent pathway [23] and also increases S1P levels [24] [25] [26] , it was of interest to investigate the role of SphK and S1P in the regulation of GTP cyclohydrolase and BH 4 biosynthesis. We found that stimulation of SphK and generation of intracellular S1P by TNF-α was involved in the regulation of GTP cyclohydrolase expression and activity, as the SphK inhibitor, N,N-dimethylsphingosine, completely blocked the potentiation effect of SphK on TNF-α-induced GTP cyclohydrolase and BH 4 synthesis [27] . Remarkably, exogenous S1P or dihydro-S1P (sphinganine 1-phosphate), which both bind to and activate all of the S1P receptors, did not mimic the effect of overexpression of SphK and increased intracellular S1P on GTP cyclohydrolase expression and activity or on BH 4 biosynthesis [27] . This was not due to a failure to activate S1P receptors on C6 cells, as binding of S1P and dihydro-S1P to S1P 1 present on C6 cells markedly activated ERK (extracellular-signal-regulated kinase). It was previously shown that activation of ERK by S1P leads to induction of expression of Egr-1, one of the immediate early gene products required for expression of this essential transcription factor for fibroblast growth factor-2, an autocrine factor that stimulates proliferation of astroglial cells [28, 29] . Interestingly, overexpression of SphK1 not only potentiated TNF-α-induced BH 4 biosynthesis, but also, similar to its effect on fibroblasts [14, 30] , enhanced proliferation of C6 cells. However, whereas this proliferative effect could be blocked by PD90859, an inhibitor of the ERK pathway, similar treatment had no effect on TNF-α-induced BH 4 biosynthesis. Thus, although some effects of S1P, such as ERK activation, are clearly mediated through interactions with S1P receptors, BH 4 biosynthesis is only regulated by intracellularly generated S1P, not by exogenous S1P, and GTP cyclohydrolase may be an intracellular target of S1P.
One of the important functions of astroglial cells is to support neuronal cells by secreting a variety of neurotrophic factors, such as fibroblast growth factor-2 and other peptide growth factors, and neurotransmitters [31] . It should be noted that S1P can act in an autocrine or paracrine manner through different members of the S1P receptor family present on both astroglial and neuronal cells. S1P may therefore be another factor provided by glial cells in vivo to promote neuronal cell survival and morphology rearrangements and remodelling of the actin cytoskeleton during various stages of development. Alternatively, it could have pathophysiological effects at sites of brain lesions and alter the blood-brain barrier [32] .
SphK promotes growth and survival independent of S1P receptors
Expression of SphK1 elevated intracellular levels of S1P, expedited the G 1 /S transition, protected against apoptosis [14] and enhanced tumour formation in mice [30, 33] . Heterotrimeric G-proteins couple cell-surface receptors to signals that regulate proliferation and survival, and asynchronous activation of Gα subunits can lead to oncogenic transformation [34] . Moreover, in some cases it is the Gβγ dimers that mediate proliferation via ERK1/2 activation and promote cell survival by activation of phosphoinositide 3-kinase [35] . The many studies implicating G-protein-coupled S1P receptors in the biological activities of S1P have overshadowed its intracellular roles, mainly due to the difficulty of dissociating signals that originate at the cell surface from those potentially originating inside cells. Pertussis toxin, which ADPribosylates and inactivates G i proteins, has frequently been used to implicate a Gα i -mediated pathway in proliferative and survival effects induced by exogenous S1P [13, 36, 37] . However, while pertussis toxin did not affect the proliferation and cytoprotective effects induced by SphK1 overexpression, these were completely blocked by a SphK inhibitor [14] . In agreement, inhibiting α ι and α q , but not α 12/13 , drastically reduced proliferation and ERK1/2 activation induced by exogenous S1P. In sharp contrast, blocking signalling of the various Gα subunits and Gβγ dimers, the G-proteins that S1P receptors couple to and signal through, did not influence growth and survival promoted by SphK1 and intracellularly generated S1P [38] . Thus although the mitogenic effect of exogenous S1P appears to be mediated by binding to cellsurface S1P receptors, S1P formed by overexpression of SphK1 promoted growth and survival independently of these receptors. In further support of this conclusion, expression of SphK1 markedly stimulated growth of pertussis toxin-treated S1P 2 /S1P 3 double-knockout mouse embryonic fibroblasts, which then have no functional S1P receptors [38] . In contrast with the strong mitogenic effect of SphK1 in pertussis toxintreated S1P 2 /S1P 3 double-knockout embryonic fibroblasts, no significant responses were observed with exogenous S1P [38] . These results suggest that S1P receptors are dispensable for the mitogenic effect of SphK1 but contribute to that of exogenous S1P. Moreover, pertussis toxin slightly reduced the protective effects of serum and high concentrations of S1P. In contrast, pertussis toxin did not decrease the strong cytoprotective effect of SphK1 overexpression in either wildtype or S1P receptor-null embryonic fibroblasts [38] . In summary, even in the absence of all S1P receptor signalling, SphK1 still markedly induced growth and survival. These data indicate that exogenous and intracellularly generated S1P affect cell growth and survival by divergent pathways. Moreover, although intracellularly generated S1P can signal inside-out to regulate cytoskeletal rearrangements and cell movement, this is not the case for the regulation of cell growth and suppression of apoptosis, which is independent of S1P receptors.
Several other lines of evidence further support the concept of intracellular actions of S1P. First, dihydro-S1P, which is identical to S1P and only lacks the 4,5-trans double bond, binds to all of the S1P receptors, yet does not mimic the effects of S1P on cell survival [13, 16, 19, 24] . Secondly, elevation of intracellular S1P by microinjection mobilizes calcium [11] and enhances proliferation and survival [13, 16, 39] . Thirdly, SphK1 and conversion of sphingosine into S1P mediates vascular endothelial growth factor-induced activation of Ras leading to activation of the ERK pathway and cell division by inhibiting the GTPase-activating protein, RasGAP, without the participation of S1P receptors [40] . Fourthly, levels of phosphorylated long-chain sphingoid bases regulate yeast environmental stress responses and survival although they do not have any S1P receptors [41] [42] [43] , in a manner reminiscent of the function of S1P in eukaryotic cells. Accumulated sphingoid bases in yeast induce G 0 /G 1 arrest, and the yeast SphKs, Lcb4 and Lcb5, remove the sphingoid block, allowing progression to S phase [43] . Similarly, PDGFinduced activation of CDK2, a cyclin-dependent kinase that promotes cell-cycle progression, was dependent on SphK [44] . This might be due to nuclear formation of S1P, as the time course for CDK2 activation is similar to that of the increase in nucleoplasmic SphK activity and translocation to the nuclear envelope induced by PDGF [45] . Finally, S1P regulates guard cell aperture in plants, which do not have S1P receptors, by direct effects on heterotrimeric Gα proteins. Recent studies with the tobacco plant Arabidopsis thaliana suggest that S1P links the drought hormone, abscisic acid, to regulation of stomatal aperture and guard cell ion channels [46] . Interestingly, S1P regulated stomatal apertures and guard cell inward K + channels and slow anion channels only in wild-type Arabidopsis cells, but not in cells with a knockout of GPA1, their only heterotrimeric G-protein α subunit gene [46] . These results suggest that S1P may be able to activate G-proteins directly, independently of cell-surface receptors. Whether S1P can also activate heterotrimeric G-proteins in eukaryotic cells in a similar fashion remains to be determined.
In conclusion, the concept of intracellular actions of S1P independent of S1P receptors and 'inside-out signalling' is not only important for understanding S1P functions, but may have therapeutic implications for development of SphK inhibitors for treatment of cancer [30] and also for prevention of radiation-induced premature ovarian failure and infertility [16, 39] .
